.jpeg)
Medicare prices for Pirfenidone
Pirfenidone (Pirfenidone) is a pyridone derivative with anti-inflammatory, anti-fibrotic and antioxidant properties. Based on its ability to slow down functional decline and disease progression, it is approved for the treatment of idiopathic pulmonary fibrosis. It has been approved for marketing in China under the trade name of Asri and has entered the category B medical market. The scope of insurance is limited to patients with idiopathic pulmonary fibrosis. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. The specifications produced by domestic pharmaceutical factoriesThe price of 100mg*54 capsules per box is around RMB 500. This drug may be sold in domestic pharmacies or hospitals.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
